ProtoKinetix, Incorporated Logo

ProtoKinetix, Incorporated

PKTX

(1.0)
Stock Price

0,01 USD

-6594.25% ROA

-207.69% ROE

-7.91x PER

Market Cap.

7.082.592,00 USD

0% DER

0% Yield

0% NPM

ProtoKinetix, Incorporated Stock Analysis

ProtoKinetix, Incorporated Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ProtoKinetix, Incorporated Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

3 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

4 ROE

Negative ROE (-207.69%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-6594.25%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (13.78x) suggests it's overvalued, potentially making it an expensive investment.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

ProtoKinetix, Incorporated Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ProtoKinetix, Incorporated Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

ProtoKinetix, Incorporated Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ProtoKinetix, Incorporated Revenue
Year Revenue Growth
2000 0
2001 124 100%
2002 0 0%
2003 0 0%
2004 0 0%
2005 2.000 100%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ProtoKinetix, Incorporated Research and Development Expenses
Year Research and Development Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 209.532 100%
2005 410.650 48.98%
2006 180.709 -127.24%
2007 996.538 81.87%
2008 405.281 -145.89%
2009 175.958 -130.33%
2010 161.508 -8.95%
2011 117.415 -37.55%
2012 0 0%
2013 74.500 100%
2014 13.750 -441.82%
2015 158.890 91.35%
2016 450.899 64.76%
2017 296.515 -52.07%
2018 337.067 12.03%
2019 369.520 8.78%
2020 527.291 29.92%
2021 435.872 -20.97%
2022 448.873 2.9%
2023 85.180 -426.97%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ProtoKinetix, Incorporated General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 5.155.642 100%
2005 0 0%
2006 0 0%
2007 1.719.731 100%
2008 1.121.537 -53.34%
2009 1.070.151 -4.8%
2010 1.211.904 11.7%
2011 787.518 -53.89%
2012 173.118 -354.9%
2013 347.677 50.21%
2014 370.427 6.14%
2015 1.097.707 66.25%
2016 1.070.727 -2.52%
2017 1.212.462 11.69%
2018 875.970 -38.41%
2019 3.825.376 77.1%
2020 7.114.199 46.23%
2021 1.890.438 -276.33%
2022 1.399.986 -35.03%
2023 191.636 -630.54%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ProtoKinetix, Incorporated EBITDA
Year EBITDA Growth
2000 -35
2001 -16.902 99.79%
2002 -14.878 -13.6%
2003 -1.517.344 99.02%
2004 -5.364.921 71.72%
2005 -4.542.917 -18.09%
2006 -1.954.747 -132.4%
2007 -2.715.251 28.01%
2008 -1.550.392 -75.13%
2009 -1.246.109 -24.42%
2010 -1.364.772 8.69%
2011 -1.219.933 -11.87%
2012 -173.118 -604.68%
2013 -422.177 58.99%
2014 -384.177 -9.89%
2015 -1.263.869 69.6%
2016 -1.521.626 16.94%
2017 -1.508.977 -0.84%
2018 -1.213.037 -24.4%
2019 -4.194.896 71.08%
2020 -7.641.490 45.1%
2021 -2.326.310 -228.48%
2022 -1.848.859 -25.82%
2023 -276.816 -567.9%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ProtoKinetix, Incorporated Gross Profit
Year Gross Profit Growth
2000 0
2001 124 100%
2002 0 0%
2003 0 0%
2004 0 0%
2005 2.000 100%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ProtoKinetix, Incorporated Net Profit
Year Net Profit Growth
2000 -35
2001 -16.902 99.79%
2002 -14.878 -13.6%
2003 -1.528.995 99.03%
2004 -5.388.274 71.62%
2005 -5.096.296 -5.73%
2006 -1.967.633 -159.01%
2007 -2.728.269 27.88%
2008 -1.550.818 -75.92%
2009 -1.270.109 -22.1%
2010 -1.388.772 8.54%
2011 -1.231.933 -12.73%
2012 -197.118 -524.97%
2013 -448.577 56.06%
2014 -168.479 -166.25%
2015 -1.254.793 86.57%
2016 -1.524.638 17.7%
2017 -1.513.634 -0.73%
2018 -1.216.343 -24.44%
2019 -4.197.897 71.02%
2020 -7.644.490 45.09%
2021 -2.329.310 -228.19%
2022 -1.907.309 -22.13%
2023 -321.564 -493.14%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ProtoKinetix, Incorporated Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ProtoKinetix, Incorporated Free Cashflow
Year Free Cashflow Growth
2000 -35
2001 -16.902 99.79%
2002 -7.889 -114.25%
2003 4.680 268.57%
2004 -390.792 101.2%
2005 -587.485 33.48%
2006 -380.456 -54.42%
2007 -645.265 41.04%
2008 -439.448 -46.84%
2009 -219.428 -100.27%
2010 -114.876 -91.01%
2011 -396.635 71.04%
2012 -149.871 -164.65%
2013 -105.341 -42.27%
2014 -229.248 54.05%
2015 -620.995 63.08%
2016 -850.043 26.95%
2017 -664.087 -28%
2018 -488.951 -35.82%
2019 -875.680 44.16%
2020 -951.486 7.97%
2021 -980.876 3%
2022 -936.718 -4.71%
2023 -71.259 -1214.53%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ProtoKinetix, Incorporated Operating Cashflow
Year Operating Cashflow Growth
2000 -35
2001 -16.902 99.79%
2002 -7.889 -114.25%
2003 4.680 268.57%
2004 -389.109 101.2%
2005 -585.780 33.57%
2006 -380.456 -53.97%
2007 -645.265 41.04%
2008 -439.448 -46.84%
2009 -219.428 -100.27%
2010 -114.876 -91.01%
2011 -396.635 71.04%
2012 -149.871 -164.65%
2013 -105.341 -42.27%
2014 -229.248 54.05%
2015 -574.235 60.08%
2016 -820.253 29.99%
2017 -605.109 -35.55%
2018 -453.493 -33.43%
2019 -850.658 46.69%
2020 -881.308 3.48%
2021 -889.891 0.96%
2022 -804.669 -10.59%
2023 -69.899 -1051.19%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ProtoKinetix, Incorporated Capital Expenditure
Year Capital Expenditure Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 1.683 100%
2005 1.705 1.29%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 46.760 100%
2016 29.790 -56.97%
2017 58.978 49.49%
2018 35.458 -66.33%
2019 25.022 -41.71%
2020 70.178 64.34%
2021 90.985 22.87%
2022 132.049 31.1%
2023 1.360 -9609.49%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ProtoKinetix, Incorporated Equity
Year Equity Growth
2000 4.965
2001 3.313 -49.86%
2002 -11.565 128.65%
2003 2.235.690 100.52%
2004 2.911.904 23.22%
2005 2.724.175 -6.89%
2006 199.249 -1267.22%
2007 -261.049 176.33%
2008 -137.627 -89.68%
2009 -248.910 44.71%
2010 -468.422 46.86%
2011 -460.355 -1.75%
2012 -507.473 9.28%
2013 -618.150 17.9%
2014 -428.329 -44.32%
2015 404.364 205.93%
2016 496.799 18.61%
2017 373.535 -33%
2018 245.965 -51.87%
2019 560.387 56.11%
2020 424.221 -32.1%
2021 352.966 -20.19%
2022 421.340 16.23%
2023 438.333 3.88%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ProtoKinetix, Incorporated Assets
Year Assets Growth
2000 5.165
2001 3.513 -47.03%
2002 579 -506.74%
2003 2.400.104 99.98%
2004 3.664.742 34.51%
2005 3.221.771 -13.75%
2006 613.950 -424.76%
2007 147.776 -315.46%
2008 257.222 42.55%
2009 263.410 2.35%
2010 69.175 -280.79%
2011 29.771 -132.36%
2012 8.426 -253.32%
2013 24.645 65.81%
2014 5.814 -323.89%
2015 449.752 98.71%
2016 542.094 17.03%
2017 518.097 -4.63%
2018 324.850 -59.49%
2019 585.907 44.56%
2020 469.181 -24.88%
2021 446.234 -5.14%
2022 462.870 3.59%
2023 450.895 -2.66%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ProtoKinetix, Incorporated Liabilities
Year Liabilities Growth
2000 200
2001 200 0%
2002 12.144 98.35%
2003 164.414 92.61%
2004 752.838 78.16%
2005 497.596 -51.3%
2006 414.701 -19.99%
2007 408.825 -1.44%
2008 394.849 -3.54%
2009 512.320 22.93%
2010 537.597 4.7%
2011 490.126 -9.69%
2012 515.899 5%
2013 642.795 19.74%
2014 434.143 -48.06%
2015 45.388 -856.51%
2016 45.295 -0.21%
2017 144.562 68.67%
2018 78.885 -83.26%
2019 25.520 -209.11%
2020 44.960 43.24%
2021 93.268 51.79%
2022 41.530 -124.58%
2023 12.562 -230.6%

ProtoKinetix, Incorporated Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-7.91x
Price To Sales Ratio
0x
POCF Ratio
-15.74
PFCF Ratio
-13.17
Price to Book Ratio
16
EV to Sales
0
EV Over EBITDA
-8.87
EV to Operating CashFlow
-15.86
EV to FreeCashFlow
-13.15
Earnings Yield
-0.13
FreeCashFlow Yield
-0.08
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.01
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.5
ROE
-2.08
Return On Assets
-1.97
Return On Capital Employed
-2
Net Income per EBT
1
EBT Per Ebit
1.01
Ebit per Revenue
0
Effective Tax Rate
0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0.21
Capex to Revenue
0
Capex to Depreciation
-1.03
Return on Invested Capital
-1.97
Return on Tangible Assets
-65.94
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.02
Current Ratio
1.07
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.97
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ProtoKinetix, Incorporated Dividends
Year Dividends Growth

ProtoKinetix, Incorporated Profile

About ProtoKinetix, Incorporated

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.

CEO
Mr. Clarence Edward Smith
Employee
0
Address
412 Mulberry Street
Marietta, 45750

ProtoKinetix, Incorporated Executives & BODs

ProtoKinetix, Incorporated Executives & BODs
# Name Age
1 Mr. Clarence Edward Smith
Chairman, President & Chief Executive Officer
70
2 Mr. Michael Richard Guzzetta CPA
Chief Financial Officer
70

ProtoKinetix, Incorporated Competitors